// App-Quantinova.ai

274 : Emergent Substitution of Fludarabine for Cyclophosphamide Due to Acute Cardiac Toxicity during Conditioning with Successful Engraftment

Researchers

Presenter

  • Hawazen Saleh Alsaedi

Principal Investigators

  • Andrew Savage

  • Michelle Hudspeth

Medical Centers

  • Medcl Univ of South Carolina, Charleston, SC

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Cardiotoxicity

  • Heart muscle disease

  • Myelofibrosis

  • Hypertension

  • Viral myocarditis

  • Graft-versus-host disease

Biomarkers

  • N/A

Drug/Treatment

  • Cyclophosphamide

  • Cyclophosphamide Injection

  • fludarabine tablet

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved